Natural course of isolated pulmonary Langerhans' cell histiocytosis in a toddler: 3-Year follow-up

Respiration

Volumn 75, Issue 2, 2008, Pages 215-220

  Nagy, Béla ^a   Soós, Györgyike ^a   Nagy, Kálmán ^b   Dezso, Balázs ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Hungarian Academy of Sciences   (Hungary)

Author keywords

Bronchoalveolar lavage; Immunohistochemistry; Langerhans' cell histiocytosis; Maternal tobacco smoke; Pediatric histiocytosis

Indexed keywords

ETOPOSIDE; PREDNISONE; VINBLASTINE;

ARTICLE; CASE REPORT; CELL ISOLATION; DISEASE COURSE; DRUG DOSE REDUCTION; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATOSPLENOMEGALY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG NODULE; LYMPHADENOPATHY; PARENT; PASSIVE SMOKING; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK FACTOR; TODDLER; TREATMENT REFUSAL;

CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; TOBACCO SMOKE POLLUTION;

EID: 40549112987     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090159     Document Type: Article

References (28)

1. Favara BE, Feller AC, Pauli M, et al: Contemporary classifi cation of histiocytic disorders. Med Pediatr Oncol 1997;29:157-166.
2. Nicholson HS, Egeler RM, Nesbit ME: The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:379-384.
3. Berlow ME, Markarian B, Heitzman ER, Raasch BN: Diffuse pulmonary disease in a 2 1/2-year-old child. JAMA 1982;248:875-876.
4. Schulze J, Kitz R, Gruttner HP, Schmidt H, Zielen S: Severe isolated pulmonary Langerhans cell histiocytosis in a 6-year-old girl. Eur J Pediatr 2004;163:320-322.
5. Delobbe A, Durieu J, Duhamel A, Wallaert B: Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Eur Respir J 1996;9:2002-2006.
6. Tazi A, Soler P, Hance AJ: Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000;55:405-416.
7. Selman M: The spectrum of smoking-related interstitial lung disorders: Chest 2003;124:1185-1187.
8. Zeid NA, Muller HK: Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995;27:247-254.
9. Travis WD, Borok Z, Roum JH, et al: Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993;17:971-986.
10. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH: Pulmonary Langerhans' cell histiocytosis. N Engl J Med 2000;342:1969-1978.
11. Tasi A, Bonay M, Grandsaigne M, Battesti JP, Hance AJ, Soler P: Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993;147:1531-1536.
12. Nagy B, Katona É, Erdei J, et al: Fibronectin in bronchoalveolar lavage fl uid and plasma from children with chronic infl ammation of lungs. Acta Paediatr Scand 1988;77:727-733.
13. Diette GB, Scatarige JC, Haponik EF, Merriman B, Fishman EK: Do high-resolution CT fi ndings of usual interstitial pneumonitis obviate lung biopsy? Views of pulmonologists. Respiration 2005;72:134-141.
14. McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J: Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child 1990;65:301-303.
15. Gadner H, Grois N, Arico M, et al: Histiocyte society. A randomised trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138:728-734.
16. Dezso B, Haas GP, Hamzavi F, et al: The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res 1996;2:1543-1552.
17. Rehli M, Krause SW, Andreesen R: The membrane-bound ectopeptidase CPM as a marker of macrophage maturation in vitro and in vivo. Adv Exp Med Biol 2000;477:205-216.
18. Nondahl SR, Finlay JL, Farrel PM, Warner TF, Hong R: A case report and literature review of 'primary' pulmonary histiocytosis X of childhood. Med Pediatr Oncol 1986;14:57-62.
19. Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM: Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol 2003;24:409-410.
20. Murakami I, Gogusev J, Fournet JC, Glorion C, Jaubert F: Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum Pathol 2002;33:555-560.
21. Vassallo P, Jensen A, Colby TV, et al: The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis. High-resolution CT, histologic, and functional correlations. Chest 2003;124:1199-1205.
22. Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL: Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1995;151:145-150.
23. Kambouchner M, Basset F, Marchal J, Uhl JF, Hance AJ, Soler P: Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2002;166:1483-1490.
24. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH: Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002;346:484-490.
25. Ryu JH, Colby TV, Hartman TE, Vassallo R: Smoking-related interstitial lung diseases: a concise review. Eur Respr J 2001;17:122-132.
26. Sundar KM, Gosselin MV, Chung HL, Cahill BC: Pulmonary Langerhans cell histiocytosis. Emerging concepts in pathobiology, and clinical evolution of disease. Chest 2003;123:1673-1683.
27. Paciocco G, Uslenghi E, Mazzarella G, Roviaro GC, Vecchi G, Harari S: Diffuse cystic lung diseases. Correlation between radiologic and functional status. Chest 2004;125:135-142.
28. McClain KL, Gonzalez JM, Jonkers R, De Juli E, Egeler M: Need for a cooperative study: pulmonary Langerhans cell histiocytosis and its management in adults. Med Pediatr Oncol 2002;39:35-39.